{"id":808694,"date":"2025-02-04T13:37:36","date_gmt":"2025-02-04T18:37:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/"},"modified":"2025-02-04T13:37:36","modified_gmt":"2025-02-04T18:37:36","slug":"lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/","title":{"rendered":"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Feb.  04, 2025  (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the \u201cClass Period\u201d).<\/p>\n<p>On December 23, 2024, a complaint was filed against the Company and certain of its officers, alleging that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in China, which eventually resulted in the AstraZeneca China President being detained by Chinese law enforcement authorities; (3) as a result, AstraZeneca understated its legal risks; (4) the foregoing, once revealed, could materially harm AstraZeneca\u2019s business activities in China; and (5) as a result, Defendants\u2019 statements about its business, operations, and prospects, were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n<p>When investors learned the truth, AstraZeneca\u2019s common stock declined precipitously, injuring investors.<\/p>\n<p>If you suffered a loss of more than $200,000 in AstraZeneca\u2019s securities, and wish to participate, or learn more, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rNkXKSLzV5pQWctJKO9EEpBwVcfiBS9YOCaiKmaysGnWy9RuubSxCh6nw1Rk1xQXtgVj4qTKy8gPQHnGO64EcqPbgd_xiozXmd0XdJo5cFY=\" rel=\"nofollow\" target=\"_blank\">click here<\/a>, or please contact our attorneys at (914) 733-7256 or via email to Andrea Farah (afarah@lowey.com) or Vincent R. Cappucci Jr. (vcappucci@lowey.com).<\/p>\n<p>Any investor who wishes to serve as Lead Plaintiff must act before <strong>February 21, 2025<\/strong>.<\/p>\n<p>\n        <strong>About Lowey Dannenberg<\/strong><br \/>\n        <br \/>Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has recovered billions of dollars on behalf of its clients.<\/p>\n<p>\n        <strong>Contact<\/strong>:<br \/>Lowey Dannenberg P.C.<br \/>44 South Broadway, Suite 1100<br \/>White Plains, NY 10601<br \/>Tel: (914) 733-7234<br \/>Email:\u00a0afarah@lowey.com<\/p>\n<p>\n        <strong>SOURCE<\/strong>: Lowey Dannenberg P.C.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWY3ZjIyMDgtYzUzMC00NjVkLWFhOGQtY2I2YTQyMDEwZDg2LTEyMDYwODc=\/tiny\/Lowey-Dannenberg-P-C-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the \u201cClass Period\u201d). On December 23, 2024, a complaint was filed against the Company and certain of its officers, alleging that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-808694","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the \u201cClass Period\u201d). On December 23, 2024, a complaint was filed against the Company and certain of its officers, alleging that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in &hellip; Continue reading &quot;Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-04T18:37:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm\",\"datePublished\":\"2025-02-04T18:37:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/\"},\"wordCount\":351,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/\",\"name\":\"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ=\",\"datePublished\":\"2025-02-04T18:37:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/","og_locale":"en_US","og_type":"article","og_title":"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk","og_description":"NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) for violations of the federal securities laws on behalf of investors who purchased or acquired AstraZeneca common stock between February 23, 2022 and December 17, 2024, inclusive (the \u201cClass Period\u201d). On December 23, 2024, a complaint was filed against the Company and certain of its officers, alleging that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced heightened legal exposure in &hellip; Continue reading \"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-04T18:37:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm","datePublished":"2025-02-04T18:37:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/"},"wordCount":351,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/","name":"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ=","datePublished":"2025-02-04T18:37:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MjkzMSM2NzM1MzY2IzIxOTQ1MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-astrazeneca-plc-astrazeneca-or-the-company-nasdaq-azn-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lowey Dannenberg Notifies AstraZeneca PLC (\u201cAstraZeneca\u201d or the \u201cCompany\u201d) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/808694","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=808694"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/808694\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=808694"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=808694"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=808694"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}